Skip to main content

Advertisement

SpringerLink
Log in

Haste makes waste, but lack of urgency is opportunity lost

  • Rebuttal Letter
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vaidya JS, Wenz F, Bulsara M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383:603–613

    Article  PubMed  Google Scholar 

  2. Group EBCTC (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  Google Scholar 

  3. Group EBCTC (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378:1707–1716

    Article  Google Scholar 

  4. Vaidya JS, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376:91–102

    Article  PubMed  Google Scholar 

  5. Wickberg A, Holmberg L, Adami HO et al (2014) Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol 32:791–797

    Article  PubMed  Google Scholar 

  6. Vaidya JS, Wenz F, Bulsara M et al (2014) Radiotherapy for breast cancer, the TARGIT-A trial—Authors’ reply. Lancet 383:1719–1720

    Article  PubMed  Google Scholar 

  7. Esserman LJ, Alvarado MD, Howe RJ et al (2014) Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? Breast Cancer Res Treat 144:371–378

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California, San Francisco, CA, USA

    Laura Esserman, Mitchell Hayes & Michael Alvarado

Authors
  1. Laura Esserman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitchell Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Alvarado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Esserman.

Additional information

This rebuttal letter refers to the letter to the editor article available at doi:10.1007/s10549-014-3032-5.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esserman, L., Hayes, M. & Alvarado, M. Haste makes waste, but lack of urgency is opportunity lost. Breast Cancer Res Treat 147, 223–224 (2014). https://doi.org/10.1007/s10549-014-3036-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3036-1

Keywords

Search

Navigation